MedPath

Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer

Phase 2
Completed
Conditions
Rectal Cancer
Registration Number
NCT01129700
Lead Sponsor
National Cancer Center, Korea
Brief Summary

Concurrent chemoradiotherapy (CRT)

* Radiotherapy 25 ㏉/5 fractions (start concomitantly at D1)

* ↓ ↓ ↓ ↓ ↓

* Radical surgery 6 weeks after completion of chemoradiotherapy

* ↑ ↑ ↑ ↑ ↑ D1 - - - - - D5

* 5-Fluorouracil 400㎎/㎡/day + LV 20㎎/㎡/day IV bolus during the radiotherapy

Detailed Description

Radiotherapy using tomotherapy is delivered in 5 Gy daily fractions for a total of 25 Gy in 5 fractions.

A bolus injection of 5-fluorouracil (400 mg/m2/d)and leucovorin (20 mg/m2/d) is delivered concurrently on day 1-5 during radiotherapy.

Total mesorectal excision is performed within 6±2 weeks. The pathological response of downstaing is the study endpoint.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
To evaluate the pathologic responseAfter surgery with pathology data

downstaging(ypT0-2N0M0)rate

Secondary Outcome Measures
NameTimeMethod
Tumor regression grade & MR volumetryAfter surgery with pathology data for TRG, at the pretreatment work-up and 1-4 days befor surgery

To evaluate the tumor regression grade \& MR volumetry

Acute/ late toxicitiespreoperative CCRT to 3 months after surgery

To evaluate the acute and late toxicities

Trial Locations

Locations (1)

National Cancer Center Korea

🇰🇷

Goyang-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath